洞察市场格局
解锁药品研发情报

400客服电话

  • 购买数据产品

    400-9696-311 转1

  • 定制咨询业务

    400-9696-311 转2

  • 数据与AI定制业务

    400-9696-311 转3

  • 商务合作及其他问题

    400-9696-311 转4

  • 投诉及建议

    400-9696-311 转5

医药数据查询

【ChiCTR-IPR-17011233】對香港自閉症譜系兒童及其家庭進行正念訓練改善其健康狀况

基本信息
登记号

ChiCTR-IPR-17011233

试验状态

尚未开始

药物名称

/

药物类型

/

规范名称

/

首次公示信息日的期

2017-04-24

临床申请受理号

/

靶点

/

适应症

Autism Spectrum Disorder

试验通俗题目

對香港自閉症譜系兒童及其家庭進行正念訓練改善其健康狀况

试验专业题目

對香港自閉症譜系兒童及其家庭進行正念訓練改善其健康狀况

申办单位信息
申请人联系人
请登录查看
申请人名称
请登录查看
联系人邮箱
请登录查看
联系人邮编

联系人通讯地址
请登录查看
临床试验信息
试验目的

The goals of this project are to 1) reduce public stigma towards people and families with ASD and to improve the wellbeing of people and families with ASD in Hong Kong; 2) to evaluate the acceptability and effectiveness of a mindfulness training programme for adolescents with ASD and their parents for the first time in Hong Kong. The objectives of this project are to: 1) improve public awareness of ASD in Hong Kong 2) improve social responsiveness and reduce problem behaviours of adolescents with ASD 3) reduce parental stress and improve parenting style of parents of adolescents with ASD 4) develop and improve the expertise of health professionals in providing mindfulness interventions for adolescents with ASD.

试验分类
请登录查看
试验类型

随机平行对照

试验分期

探索性研究/预试验

随机化

After the baseline visit, participants will be randomly assigned to one of the treatment groups by using a list of computer-generated random numbers. This generation of random numbers and assignment will be performed by an independent statistician.

盲法

The participants and instructors by nature will be informed of the randomisation allocation results, however, the trained research assistant/associate who conducts the assessments and the statistician who conducts the data analysis will be kept blinded of the grouping.

试验项目经费来源

FOOD AND HEALTH BUREAU, HONG KONG SAR

试验范围

/

目标入组人数

16

实际入组人数

/

第一例入组时间

2017-07-05

试验终止时间

2018-07-04

是否属于一致性

/

入选标准

The inclusion criteria of participants for the training will be children aged 12 to 18 years who have received a diagnosis of Autism Spectrum Disorders (ASD) by a doctor and also one of their parents agrees to participate in the MYmind training. Furthermore, if the child is on medication for ASD, the parents should have confirmed that they do not intend to change the medication status of their child during the study period. Parents will be asked to bring a copy of the ASD diagnosis of their children from a clinical doctor, usually a psychiatrist, for confirmation of the ASD diagnosis during the interview before they attend the MYmind training programme.;

排除标准

The exclusion criteria will be: 1) being unable to communicate and understand Chinese language as the intervention will be conducted in Chinese; 2)having a medical condition rendering him/her to be incapable to participate in the study; 3) unwilling or unable to give consent; 4) having substance dependence within the past 6 months, or a history of mental retardation, borderline and antisocial personality disorder, chronic suicidal and self-injurious behavior; or 5) participating in another ongoing psychological intervention.;

研究者信息
研究负责人姓名
请登录查看
试验机构

HEALTH CARE AND PROMOTION FUND

研究负责人电话
请登录查看
研究负责人邮箱
请登录查看
研究负责人邮编

/

联系人通讯地址
请登录查看
更多信息
获取更多临床信息查看权限
立即前往摩熵医药企业版免费查询
示例数据
<END>

最新临床资讯

摩熵医药企业版
50亿+条医药数据随时查
7天免费试用

全球药物研发中心
全球研发数据与行业前沿情报

383,318
全球在研药物数
964
本月临床试验数
全球批准的新药
更多
全球首批
各国首批
数据来源:摩熵医药
更新时间:
研发动态
相关报告
政策法规
更多信息,请进入全球药物研发中心查看

医药市场洞察中心
医药市场销售数据分析 · 智能洞察 · 竞争格局监测

2,630亿元
2026年Q2总销售额
6.14%(2026Q2)
TOP5企业市场份额
药品销售排行榜
查看完整数据
2025Q4医院化学药销售增速 *按市场份额排序
  • 1
    甲氨蝶呤注射液
  • 2
    克霉唑阴道乳膏
  • 3
    氯化钠注射液
核心能力
  • 医药市场销售数据分析 · 医院、实体药店、网上药店
  • 市场竞争格局分析(靶点、药品类型、ATC大类)
更多信息,请进入医药市场洞察中心查看